Second Sight Medical Products Inc.

7.36-0.8400-10.24%Vol 2.31M1Y Perf 374.85%
Apr 16th, 2021 16:00 DELAYED
BID7.35 ASK7.55
Open7.57 Previous Close8.20
Pre-Market- After-Market7.34
 - -  -0.02 -0.27%
Target Price
12.00 
Analyst Rating
Strong Buy 1.00
Potential %
63.04 
Finscreener Ranking
★★+ —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     38.41
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     37.83
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap171.12M 
Earnings Rating
Neutral
Price Range Ratio 52W %
34.54 
Earnings Date
1st Apr 2021

Today's Price Range

7.097.62

52W Range

0.690020.00

5 Year PE Ratio Range

-3.40-0.3000

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
-16.93%
1 Month
-48.53%
3 Months
330.41%
6 Months
760.82%
1 Year
374.85%
3 Years
-47.13%
5 Years
-82.17%
10 Years
-

TickerPriceChg.Chg.%
EYES7.36-0.8400-10.24
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Financial StrengthValueIndustryS&P 500US Markets
0.60
0.80
0.25
0.00
-
Leverage Ratio 6.10
ProfitabilityValueIndustryS&P 500US Markets
75.10
-3 915.30
-3 864.60
-973.20
-
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-50.53
-30.37
Earnings HistoryEstimateReportedSurprise %
Q02 2020--0.15-
Q04 2019-0.49-0.474.08
Q03 2019-0.48-0.480.00
Q02 2019-0.48-0.56-16.67
Q01 2019-0.48-0.80-66.67
Q04 2018-0.88-0.880.00
Q03 2018-1.12-0.9614.29
Q02 2018-0.14-0.1214.29
Earnings Per EndEstimateRevision %Trend
9/2020 QR-0.410.00-
12/2020 QR-0.420.00-
12/2020 FY-1.640.00-
12/2021 FY-1.390.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2.31M
Shares Outstanding23.25M
Trades Count11.68K
Dollar Volume835.62K
Avg. Volume21.65M
Avg. Weekly Volume2.68M
Avg. Monthly Volume6.86M
Avg. Quarterly Volume24.74M

Second Sight Medical Products Inc. (NASDAQ: EYES) stock closed at 7.36 per share at the end of the most recent trading day (a -10.24% change compared to the prior day closing price) with a volume of 2.32M shares and market capitalization of 171.12M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 112 people. Second Sight Medical Products Inc. CEO is Matthew J. Pfeffer.

The one-year performance of Second Sight Medical Products Inc. stock is 374.85%, while year-to-date (YTD) performance is 293.58%. EYES stock has a five-year performance of -82.17%. Its 52-week range is between 0.69 and 20, which gives EYES stock a 52-week price range ratio of 34.54%

Second Sight Medical Products Inc. currently has a PE ratio of -10.20, a price-to-book (PB) ratio of 613.43, a price-to-sale (PS) ratio of 101.87, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -132.08%, a ROC of -248.70% and a ROE of -410.57%. The company’s profit margin is -%, its EBITDA margin is -3 864.60%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Second Sight Medical Products Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Second Sight Medical Products Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Second Sight Medical Products Inc. is Strong Buy (1), with a target price of $12, which is +63.04% compared to the current price. The earnings rating for Second Sight Medical Products Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Second Sight Medical Products Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Second Sight Medical Products Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 42.06, ATR14 : 1.54, CCI20 : -98.99, Chaikin Money Flow : -0.14, MACD : 1.77, Money Flow Index : 73.71, ROC : -5.88, RSI : 82.11, STOCH (14,3) : 7.54, STOCH RSI : 0.00, UO : 34.33, Williams %R : -92.46), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Second Sight Medical Products Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (50.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.50

Second Sight Medical Products Inc.

Second Sight Medical Products Inc develops, manufactures and markets implantable prosthetic devices, to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, France and Germany, of which key revenue is derived from the United States.

CEO: Matthew J. Pfeffer

Telephone: +1 818 833-5000

Address: 12744 San Fernando Road, Sylmar 91342, CA, US

Number of employees: 112

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

53%47%

News

Stocktwits